Cited by 32Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

Revisiting atherosclerosis and dementia

Open access
Iadecola, Costantino·2020·Nature Neuroscience

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41593-020-0626-6

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Atherosclerosis is an important factor leading to cognitive impairment in the elderly via mechanisms such as ischemia and a direct molecular link.

    “Additionally, atherosclerosis is an important factor leading to cognitive impairment in the elderly via several mechanisms such as ischemia and a direct molecular link [2,3].”

    From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [3]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [5]Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM & Evans AC Nat. Commun 7, 11934 (2016). 27327500 PMC4919512
  2. [7]Preische O Nat. Med 25, 277– 283 (2019). 30664784 PMC6367005

Cited by

Sorted by citations

Authors
Iadecola, C.
Affiliations
Weill Cornell Medicine (US)
Corresponding author
Iadecola, Costantino
Venue
Nature Neuroscience
Published
2020-05-18
Volume
23
Issue
6
Pages
691-692
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W3025682932
Cited by
32
References
14
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 2
FWCI
3.83
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Neurological Disorders and Stroke (R01NS037853)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
atherosclerosis, dementia, intracranial atherosclerosis, Alzheimer's disease, proteome-wide association study, cerebrovascular disease, neurodegeneration
MeSH terms
Alzheimer Disease, Brain, Intracranial Arteriosclerosis, Humans, Proteomics, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review